Radiobiologia: High dose per fraction. Lidia Strigari Laboratorio di Fisica Medica e Sistemi Esperti SBRT

Similar documents
The Radiobiological Four "R"s of Hypofractionation. Brian Marples PhD Beaumont Health Systems

Cell survival following high dose rate flattening filter free (FFF) and conventional dose rate irradiation

The Four R s. Repair Reoxygenation Repopulation Redistribution. The Radiobiology of Small Fraction Numbers. The Radiobiology of Small Fraction Numbers

Radiobiology of high dose per fraction

Radiobiology of fractionated treatments: the classical approach and the 4 Rs. Vischioni Barbara MD, PhD Centro Nazionale Adroterapia Oncologica

7/16/2009. An overview of classical radiobiology. Radiobiology and the cell kill paradigm. 1. Repair: Radiation cell killing. Radiation cell killing

Radiation Oncology. Initial Certification Qualifying (Computer-based) Examination: Study Guide for Radiation and Cancer Biology

BASIC CLINICAL RADIOBIOLOGY

Non-classical radiobiology relevant to high-doses per fraction

The Impact of Cobalt-60 Source Age on Biologically Effective Dose in Gamma Knife Thalamotomy

Flattening Filter Free beam

New Thinking on Fractionation in Radiotherapy

CHAPTER TWO MECHANISMS OF RADIATION EFFECTS

UNC-Duke Biology Course for Residents Fall

Radiobiological principles of brachytherapy

Hypofractionation in particle therapy. Marco Durante

Use of radiation to kill diseased cells. Cancer is the disease that is almost always treated when using radiation.

Fractionation: why did we ever fractionate? The Multiple Fractions School won! Survival curves: normal vs cancer cells

Radiobiological modelling applied to Unsealed Source (radio) Therapy

Radiotherapy physics & Equipments

The Radiation Biology of Dose Fractionation: Determinants of Effect

Clinical Applications of Brachytherapy Radiobiology. Radiobiology is Essential

Hypofractionated radiation therapy for glioblastoma

Radiobiological Models in Brachytherapy Planning and Evaluation

ISOEFFECT CALCULATION IN HDR BRACHYTHERAPY (BASIC CLINICAL RADIOBIOLOGY)

Linac or Non-Linac Demystifying And Decoding The Physics Of SBRT/SABR

Hypofractionation in prostate cancer radiotherapy

Innovazioni tecnologiche in Radioterapia" Sergio Fersino Radioterapia Oncologica

Can the two mechanisms of tumor cell killing by radiation be exploited for therapeutic gain?

The temporal pattern of dose delivery in external beam radiotherapy

Research Article A Mathematical Model of Tumor Volume Changes during Radiotherapy

TFY4315 STRÅLINGSBIOFYSIKK

Individualized dosimetry treatment planning for liver irradiation

Treatment Planning. G. Battistoni INFN Milano

The dependence of optimal fractionation schemes on the spatial dose distribution

Dosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer

Chapter 14 Basic Radiobiology

The Evolution of SBRT and Hypofractionation in Thoracic Radiation Oncology

The Promise and Pitfalls of Mechanistic Modeling in Radiation Oncology

Treatment Planning for Lung. Kristi Hendrickson, PhD, DABR University of Washington Dept. of Radiation Oncology

Hidden Issues in the Use of LQ. Disclosure

Biological consequences of radiation therapy: a new era of normal tissue, cancer and immune biology

Acknowledgments. Introduction. Managing the Care of Radiotherapy Patients Implanted with Cardiac Devices. Outline

Therapeutic ratio - An Overview. Past Present Future Prof Ramesh S Bilimaga

Radiation Therapy and Immunotherapy: New Frontiers

Radiation Treatment Techniques: Where to find rooms for improvement?

Radiation Therapy and Immunotherapy: New Frontiers

Risk of secondary cancer induced by radiotherapy

Dosimetry and radiobiology for Peptide Receptor Radionuclide Therapy

WHAT HYPOFRACTIONATED PROTOCOLS SHOULD BE TESTED FOR PROSTATE CANCER?

HALF. Who gets radiotherapy? Who gets radiotherapy? Half of all cancer patients get radiotherapy. By 1899 X rays were being used for cancer therapy

SBRT in early stage NSCLC

Marco Trovò CRO-Aviano

Advances in external beam radiotherapy

Overview of Advanced Techniques in Radiation Therapy

by Lingshu Yin B.Sc. Nanjing University 2006 A THESIS SUBMITTED IN PARTIAL FULFILMENT OF THE REQUIREMENT FOR THE DEGREE OF Master of Science

The Paul Evans Memorial Lecture Functional radiotherapy targeting using focused dose escalation. Roberto Alonzi Mount Vernon Cancer Centre

Overview of Clinical and Research Activities at Georgetown University Hospital

I TESSUTI: Dott.ssa Liliana Belgioia Università degli Studi di Genova

Radiobiology of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy

RADIOBIOLOIGCALLY BASED TREATMENT PLANNING: THE NEXT FRONTIER. Teddy LaMaster, MS

Dose escalation in permanent brachytherapy for prostate cancer: dosimetric and biological considerations*

Future of Radiation Therapy

Evaluation of Monaco treatment planning system for hypofractionated stereotactic volumetric arc radiotherapy of multiple brain metastases

Imaging of Scattered Radiation for Real Time Tracking of Tumor Motion During Lung SBRT

HDR Applicators and Dosimetry*

Lecturer: Dr. David Murray March 18th, 2008

Tecniche Radioterapiche U. Ricardi

Would SBRT Hypofractionated Approach Be as Good? Then Why Bother With Brachytherapy?

Radiobiology for particle therapy

Radiotherapy What are our options and what is on the horizon. Dr Kevin So Specialist Radiation Oncologist Epworth Radiation Oncology

6/29/2012 WHAT IS IN THIS PRESENTATION? MANAGEMENT OF PRIMARY DEVICES INVESTIGATED MAJOR ISSUES WITH CARDIAC DEVICES AND FROM MED PHYS LISTSERVS

Re irradiation volumetric modulated arc therapy optimization based on cumulative biologically effective dose objectives

Sarcoma and Radiation Therapy. Gabrielle M Kane MB BCh EdD FRCPC Muir Professorship in Radiation Oncology University of Washington

Hypofractionation and positioning in breast cancer radiation. John Hardie, M.D., Ph.D. November 2016

CyberKnife Radiotherapy For Localized Prostate Cancer: Rationale And Technical Feasibility

Ranking radiotherapy treatment plans: physical or biological objectives?

PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015)

MEDICAL MANAGEMENT POLICY

COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE

On the use of 4DCT derived composite CT images in treatment planning of SBRT for lung tumors

7/31/2012. Volumetric modulated arc therapy. UAB Department of Radiation Oncology. Richard Popple, Ph.D.

RADIOBIOLOGICAL PRINCIPLES IN INTRAVASCULAR IRRADIATION

Lung SBRT in a patient with poor pulmonary function

Stereotactic Ablative Radiotherapy for Prostate Cancer

Technique For Plan Quality and Efficiency Using VMAT Radiosurgery For Patients with Multiple Brain Metastases

A dosimetric comparison between volumetric-modulated arc therapy and dynamic conformal arc therapy in SBRT

Partial Breast Irradiation using adaptive MRgRT

New Radiation Treatment Modalities in the Treatment of Lung Cancer

Application of the concept of biologically effective dose (BED) to patients with Vestibular Schwannomas treated by radiosurgery

SRS/SBRT Errors and Causes

Radiation Related Second Cancers. Stephen F. Kry, Ph.D., D.ABR.

A SIMPLE METHOD OF OBTAINING EQUIVALENT DOSES FOR USE IN HDR BRACHYTHERAPY

Radiation Damage Comparison between Intensity Modulated Radiotherapy (IMRT) and Field-in-field (FIF) Technique In Breast Cancer Treatments

Optimising Radiotherapy Using NTCP Models: 17 Years in Ann Arbor

The impact of cobalt-60 source age on biologically effective dose in high-dose functional Gamma Knife radiosurgery

Determination and Use of Radiobiological Response Parameters in Radiation Therapy Optimization. Panayiotis Mavroidis

Lung Cancer Radiotherapy

Mathematical optimization of treatment schedules

International Open Laboratory at NIRS (Second Term)

Transcription:

Radiobiologia: High dose per fraction Lidia Strigari Laboratorio di Fisica Medica e Sistemi Esperti SBRT Although SBRT constitutes a potpourri of technologies and techniques, including threedimensional conformal, intensity modulation, image guidance, motion control, and stereotactic targeting, the hallmark of SBRT is delivery of a potent, ablative or nearly ablative dose in oligofractions (i.e., five or fewer fractions). 1

outline What is the biological basis of potent hypofractionation used in SRS and SBRT? Does LQ model work at high doses? What effect does occur increasingly at higher doses per fraction? Are 4Rs of radiobiology still relevant to SRS/ SBRT regimens? Radiobiology Classical Radiobiology Fractionation 4Rs Cell survival curves and modeling Linear quadratic (LQ) model and modifications to LQ model to fit the data at high dose Vascular effects/endothelial cell damage at high dose Immune system effect Dose-rate effect? SBRT /SART 4Rs revisited 2

Il modello Lineare Quadratico Per semplicità è conveniente pensare che la radiazione in una cellula può produrre o un danno di tipo A o di tipo B Il danno di tipo A si ha quando un singolo evento disattiva due bersagli critici (es. due eliche del DNA); Il danno di tipo B è il danno prodotto su ogni singolo bersaglio da due eventi separati (es. ogni elica del DNA interrotta in punti diversi da due eventi separati). Nel modello Lineare Quadratico Il danno di tipo A è rappresentato dal termine D Il danno di tipo B è rappresentato dal termine D 2 3

Differenze OARs e Tumore tumor late 4

Question 1: Is the LQ model appropriate to model high dose per fraction effects in SBRT/SRS? Fowler J F 2008 Linear quadratics is alive and well: in regard to Park et al. (Int J Radiat Oncol Biol Phys 2008;70:847-852) Int J Radiat Oncol Biol Phys. 72 957 2 D BED n D D D D T / 2 DT BEDn D DT D DT D D T / Astrahan, Med. Phys. 2008 D T 2 / tg @ D T On the log-linear plot, the LQ curve closely fits these experimental results for Chinese hamster cells in culture up to a dose of 6 Gy, but then continues to bend. The experimental results are observed to become linear at high dose. 5

LQ model tends to overestimate the effectiveness of cell killing by a single high dose The essential problem stems from ignoring the reduction of sublethal damage after conversion to lethal damage; therefore the pool size of the sublethals lesions which are available to be converted to lethal lesions with further irradiation is over estimated (Wang JZ et al. Sci Transl Med. 2010) glq : α = 0.11/Gy, α/β=0.82 Gy LQ: α=0.40/gy, α/β= 16 Gy glq: α = 0.10/Gy, α/β = 0.80 Gy LQ: α = 0.15/Gy, α/β = 2.0 Gy Universal Survival Curve Park et al. 2008 6

Wennberg et al. 2013 7

NSCLC Local control rates were 89% and 62% at 36 months for >100 Gy and <100 Gy BED (p = 0.0001) α/β=10 Gy α/β=8.6 Gy NSCLC > 24 months 8

NSCLC α/β=8.6 Gy Dose rate effect Vascular effect Endothelium 9

Strigari et al. 2012 S Models LQ LQ-L 0d exp d 0 0d S d d GT 0 exp 0 0d S d exp d d h h h S d exp d GT h h d h 0 h OER h OER 0 2 R t Teff t 2 B f d, n G 0 T exp 2 d 0 h OER h OER 0 2 T 1 T 2 Guerrero M et al. 2004 Parameters B f d, n N0, h, T eff, 0, 0 h, h Nahum et al. 2003 Carlson et al. 2006 LQ LQ-L 10

For D < 5Gy oxic cells die For D > 5Gy hypoxic cells death dominates For D >10 Gy Vascular damage at high doses produces secondary cell killing, suggests that radiation doses induce vascular damage leading to indirect tumor cell death. Dose rate effect Vascular effect Endothelium 11

vasculature associated with tumors is not normal The blood vessels in a tumor bed, generally speaking, are tortuous, dilated, and poorly organized The surrounding pericytes are abnormal. They tend to be hyperpermeable and leaky 12

Dose rate effect Vascular effect Endothelium The oncologist s prospective 13

Animal model Animal model 14

IRE experience Dose rate effect Vascular effect Endothelium 15

VMAT FFF vs FF: beam hardening FFF ha una più bassa energia media 10FFF 8 Dose rate 24 Gy/min Ref. Cells E (MV) Dose rate (Gy/min) Modulate d beam Effect Sørensen et al. RO 2011 HN FaDu V79 6FFF 6X 5, 10, 30 No No Loshe et al.ro 2011 Gliomas T98G (mutp53) U87MG 10FFF 10X 0.02, 4, 24 No Yes at D 10 Gy King et al.pmb 2013 PCa DU 145, NSCLC H460 6FFF 6X 3, 11 Yes (bolus) No Verbakel et al. AO 2013 Lung SW1573 ; gliom T98 (Mut-p53); astroc D348 6/10 FFF/X 4, 8 Yes (IMRT) No Karan et al. PMB 2013 cervix SiHa; NSCLC H460; V79 6/10 FFF/X 3, 10 No No Bewes et al. 2008 melanoma MM576; NSCLC H460 6FFF 6X 1.2, 5 Yes Dose rate effect on protracted delivery 16

In vivo bystander effect: carcinogenic potential SBRT /SART 4Rs revisited Reoxygenation When tumors are treated with SRS/SBRT the intra-tumor environment will become hypoxic leading to secondary cell death due to vascular damage Repair Vascular damage and ensuing chaotic intratumor environment may significantly hinder repair of radiation damage Redistribution after irradiation with extremely high doses of radiation (>15-20 Gy), in a single fraction, cells are indefinitely arrested in the phases of cell cycle where they were irradiated and undergo interphase cell death Repopulation Since SRS/SBRT treatment courses substantially short (1-2 weeks) repopulation of tumor cells will not be substantial during the course of SBRT Not significant factors. Differential biological effect between tumor and normal tissue is largely gained through minimization of normal tissue volume in SRS and SBRT 17

Adaptive RT Liver Adaptive RT Liver 18

19

Conclusion Extreme hypofractionated RT (SBRT/SABR) seems to be capable of overcoming hypoxic radioprotection through mechanisms other than directly killing tumor cells via DNA damage. Important mechanisms for cell inactivation has been hypothesized to become important at doses >10 Gy Vascular effects occurs increasingly at higher doses per fraction Immunological effect Bystander effect 20